Skip to main content
Top
Published in: Current Infectious Disease Reports 11/2014

01-11-2014 | Healthcare Associated Infections (G Bearman and D Morgan, Section Editors)

Antimicrobial Stewardship—Qualitative and Quantitative Outcomes: The Role of Measurement

Author: Ed Septimus

Published in: Current Infectious Disease Reports | Issue 11/2014

Login to get access

Abstract

Overuse and misuse of antibiotics have contributed to the growing problem of antimicrobial resistance and serious side effects including Clostridium difficile infection. The Centers for Disease Control and Prevention estimates that more than 2 million people are infected by multidrug-resistant organisms every year. They propose that promoting antimicrobial stewardship programs (ASP) is an essential component to combat this growing threat. One of the major barriers in implementing effective ASP is the availability of reliable measures which reflect intervention effectiveness. Measuring ASP can be divided into four categories: antimicrobial consumption, process measures, outcome measures, and financial. This article reviews the strengths and weaknesses of the current measures.
Literature
1.
go back to reference Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163:972–8.PubMedCrossRef Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163:972–8.PubMedCrossRef
2.••
go back to reference Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR. 2014;63:194–200. This timely article confirmed antibiotic prescribing is common in hospitals and that there is amble opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing.PubMed Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR. 2014;63:194–200. This timely article confirmed antibiotic prescribing is common in hospitals and that there is amble opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing.PubMed
3.•
go back to reference Bell BG, Schellevis F, Stobberingh E, et al. A systemic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014; Jan 9; 14:13.doi:10:186/1471.2334-14-13. This recent article using multiple regression analysis confirmed that antibiotic consumption is associated with the development of antibiotic resistance Bell BG, Schellevis F, Stobberingh E, et al. A systemic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014; Jan 9; 14:13.doi:10:186/1471.2334-14-13. This recent article using multiple regression analysis confirmed that antibiotic consumption is associated with the development of antibiotic resistance
5.••
go back to reference Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013; 4:CD003543. This publication is an update from the analysis published in 2005. They show stewardship to reduce overuse of prescribing to hospital in patients can reduce antimicrobial resistance and HAIs and improve patient outcomes Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013; 4:CD003543. This publication is an update from the analysis published in 2005. They show stewardship to reduce overuse of prescribing to hospital in patients can reduce antimicrobial resistance and HAIs and improve patient outcomes
6.
go back to reference Chassin MR, Loeb JM, Schmaltz SP, Wachter RM. Accountability measures—using measurement to promote quality improvement. N Eng J Med. 2010;363:683–8.CrossRef Chassin MR, Loeb JM, Schmaltz SP, Wachter RM. Accountability measures—using measurement to promote quality improvement. N Eng J Med. 2010;363:683–8.CrossRef
7.
go back to reference Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–70.PubMedCrossRef Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–70.PubMedCrossRef
8.•
go back to reference Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2012;33:500–6. This article used a structured panel process to define quality improvement metrics for evaluating antimicrobial stewardship programs in the hospital setting.PubMedCrossRef Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2012;33:500–6. This article used a structured panel process to define quality improvement metrics for evaluating antimicrobial stewardship programs in the hospital setting.PubMedCrossRef
9.•
go back to reference Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatients antimicrobial use among hospitals in the United States. Clin Infect Dis. 2014;58:401–6. This article from the CDC highlights the importance of providing metrics that support facility-specific stewardship efforts. They point out no single system is currently available in the US. They describe the CDC’s effort in building a comprehensive approach to monitoring antimicrobial use in US acute care hospitals.PubMedCrossRef Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatients antimicrobial use among hospitals in the United States. Clin Infect Dis. 2014;58:401–6. This article from the CDC highlights the importance of providing metrics that support facility-specific stewardship efforts. They point out no single system is currently available in the US. They describe the CDC’s effort in building a comprehensive approach to monitoring antimicrobial use in US acute care hospitals.PubMedCrossRef
10.
go back to reference Pulcini C, Defres S, Aggarwal I, et al. Design of a ‘day 3 bundle’ to improve the reassessment of inpatient empirical antibiotic prescriptions. J Antimicrob Chemother. 2008;61:1384–8.PubMedCrossRef Pulcini C, Defres S, Aggarwal I, et al. Design of a ‘day 3 bundle’ to improve the reassessment of inpatient empirical antibiotic prescriptions. J Antimicrob Chemother. 2008;61:1384–8.PubMedCrossRef
11.
go back to reference Jacob JT, Gaynes RP. Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther. 2010;8:893–902.PubMedCrossRef Jacob JT, Gaynes RP. Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther. 2010;8:893–902.PubMedCrossRef
13.
go back to reference Ruttimann S, Keck B, Hartmeier C, et al. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348–56.PubMedCrossRef Ruttimann S, Keck B, Hartmeier C, et al. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348–56.PubMedCrossRef
14.
go back to reference Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med. 1998;128:989–95.PubMedCrossRef Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med. 1998;128:989–95.PubMedCrossRef
15.
go back to reference Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699–706.PubMedCrossRef Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699–706.PubMedCrossRef
16.
go back to reference Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112–21.PubMedCrossRef Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112–21.PubMedCrossRef
17.
go back to reference Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:388–416 Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:388–416
18.
go back to reference Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum beta-lactamase-producing Enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Dis Hosp Epidemiol. 2006;27:279–86.CrossRef Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum beta-lactamase-producing Enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Dis Hosp Epidemiol. 2006;27:279–86.CrossRef
19.
go back to reference Geissler A, Gerbeaux P, Granier I, et al. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med. 2003;29:49–54.PubMed Geissler A, Gerbeaux P, Granier I, et al. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med. 2003;29:49–54.PubMed
20.
go back to reference Standiford H, Forrest G, Granier I et al. Abstract 666: Antimicrobial stewardship: the cost of discontinuing a program. Centers for Disease Control and Prevention Society for Healthcare Epidemiology of America Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, Mar. 18–22, 2010.http://shea.confex.com/shea/2010/webprogram/Paper2417.html (accessed May 21, 2014) Standiford H, Forrest G, Granier I et al. Abstract 666: Antimicrobial stewardship: the cost of discontinuing a program. Centers for Disease Control and Prevention Society for Healthcare Epidemiology of America Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, Mar. 18–22, 2010.http://​shea.​confex.​com/​shea/​2010/​webprogram/​Paper2417.​html (accessed May 21, 2014)
21.
go back to reference Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Syst Rev 2005: CD003543 Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Syst Rev 2005: CD003543
22.
go back to reference Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53:S23–8.PubMedCrossRef Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53:S23–8.PubMedCrossRef
Metadata
Title
Antimicrobial Stewardship—Qualitative and Quantitative Outcomes: The Role of Measurement
Author
Ed Septimus
Publication date
01-11-2014
Publisher
Springer US
Published in
Current Infectious Disease Reports / Issue 11/2014
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-014-0433-x

Other articles of this Issue 11/2014

Current Infectious Disease Reports 11/2014 Go to the issue

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Neurocysticercosis: An Update

Skin, Soft Tissue, Bone and Joint Infectious Diseases (N Safdar, Section Editor)

Mycobacterial Skin and Soft Tissue Infection

Central Nervous System Infections (J Lyons, Section Editor)

Spinal Epidural Abscess

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Recent Advances in Clinical Parasitology Diagnostics

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.